癌症診療品質指標發展、監測、國際標竿及成效－以肺癌、大腸癌、乳癌及肝癌為例

Development, Monitoring, and International Benchmar-king of Quality Indicators for Cancer Diagnosis and Treatment: Lung Cancer, Colorectal Cancer, Breast Cancer, and Hepatoma

依據衛生福利部最新死因統計，癌症已連續38年蟬聯我國十大死因榜首[1]，不僅威脅國人健康，更造成國家、社會及家庭莫大損失。為提升癌症診療照護品質，國民健康署（簡稱國健署）自2004年起陸續發展11癌核心測量指標，提供醫院內部監測癌症診療品質，並透過定期分析以監測各醫院癌症防治推動情形。資料分析顯示我國部分指標表現優於德國或美國（如肺癌、大腸癌），部分指標表現則尚有努力空間（如乳癌）。

 

According to cause-of-death statistics published by Taiwan’ s Ministry of Health and Welfare in 2019, cancer has been the top cause of death for 38 consecutive years.Thus, cancer has been not only affecting the health of people but also causing substantial losses to the country, society, and family. To improve the quality of cancer diagnosis and care, the Health Promotion Administration (HPA) has successively implemented 11 core measurement indicators for cancer since 2004. Through regular analysis of these measurement indicators, the HPA monitors the quality of cancer care as well as promotes cancer prevention and treatment in various hospitals. Data analysis results showed that some indicators in Taiwan were more favorable than those used in Germany or the United States (e.g., lung cancer and colorectal cancer); however, some indicators can still be improved (e.g., breast cancer).